Medications for Hidradenitis Suppurativa

8 results

  • abrilada - adalimumab - afzb

    (Adalimumab-Afzb)
    Pfizer Laboratories Div Pfizer Inc
    Abrilada is a TNF blocker indicated for moderate-to-severe rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, juvenile idiopathic arthritis (age 2+), Crohn's disease (age 6+), ulcerative colitis, chronic plaque psoriasis, hidradenitis suppurativa, and non-infectious uveitis in adults.
    Medication Details
    Savings Programs
    1
    Drug Interactions

  • amjevita - adalimumab - atto injection

    (Adalimumab-Atto)
    Amgen, Inc
    TNF blocker for rheumatoid arthritis, polyarticular juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, plaque psoriasis, hidradenitis suppurativa, and non-infectious uveitis in adults and eligible pediatric patients.
    Medication Details
    Drug Interactions

  • bimzelx - bimekizumab injection, solution

    (Bimekizumab)
    Ucb, Inc.
    BIMZELX treats adults with moderate-to-severe plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, non-radiographic axial spondyloarthritis with objective signs of inflammation, and moderate-to-severe hidradenitis suppurativa.
    Medication Details
    Drug Interactions

  • cosentyx - secukinumab injection

    (Secukinumab)
    Novartis Pharmaceuticals Corporation
    Cosentyx treats moderate-to-severe plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, non-radiographic axial spondyloarthritis, enthesitis-related arthritis, and moderate-to-severe hidradenitis suppurativa in eligible adults and pediatric patients.
    Medication Details
    Drug Interactions

  • hadlima - adalimumab - bwwd solution

    (Adalimumab-Bwwd)
    Organon Llc
    HADLIMA is a TNF blocker for adults and children with moderately to severely active rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, plaque psoriasis, hidradenitis suppurativa, and non-infectious uveitis. Also indicated for juvenile idiopathic arthritis in patients 2 years and older.
    Medication Details
    Drug Interactions

  • hulio - adalimumab - fkjp

    (Adalimumab-Fkjp)
    Biocon Biologics Inc
    Hulio (adalimumab) is a TNF blocker indicated for rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, plaque psoriasis, hidradenitis suppurativa, and non-infectious uveitis in adults; JIA and Crohn's disease also cover pediatric patients.
    Medication Details
    Drug Interactions

  • humira - adalimumab

    (Adalimumab)
    Abbvie Inc.
    HUMIRA is a TNF blocker indicated for rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, plaque psoriasis, hidradenitis suppurativa, juvenile idiopathic arthritis, and non-infectious uveitis in adults and eligible pediatric patients.
    Medication Details
    Drug Interactions

  • yusimry - adalimumab - aqvh injection, solution

    (Adalimumab-Aqvh)
    Coherus Biosciences Inc
    YUSIMRY is a TNF blocker indicated for rheumatoid arthritis, juvenile idiopathic arthritis (age 2+), psoriatic arthritis, ankylosing spondylitis, Crohn's disease (age 6+), ulcerative colitis, plaque psoriasis, hidradenitis suppurativa, and non-infectious uveitis in adults.
    Medication Details
    Drug Interactions